On the recordNovember 16, 2015
FDA's proposal to regulate LDTs is a significant change that would impose considerable new burdens on regulated parties.
Source
congress.govFDA's proposal to regulate LDTs is a significant change that would impose considerable new burdens on regulated parties.
Hatch discusses the impact of FDA's proposed regulation on laboratory-developed tests.
Share & report
More from Orrin Hatch
You have authored landmark opinions on the separation of powers, administrative law, and national security.
Some of my colleagues do not like the environmental laws Congress has actually passed.
Do you believe that it is important for a judge to interpret and apply the laws that Congress has actually passed rather than seeking to make up or change the law if the judge does not like what the Congress has done?